Trading Signals: HALO Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Halozyme Therapeutics Inc)
| HALO latest price $25.8850 (-0.67%) ($25.7300 - $26.3800) on Mon. Sep. 28, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.2% (three month average) | RSI | 35 | Latest Price | $25.8850(-0.67%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | HALO declines -0.6% a day on average for past five trading days. | Weekly Trend | HALO declines -2.8% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support HALO advance at 0% a week (0% probability) IWO(50%) IBB(49%) IWM(48%) IWC(45%) ARKG(41%) | Factors Impacting HALO price | HALO will decline at least -1.1% in a week (0% probabilities). VIXM(-31%) UUP(-15%) VXX(-13%) EDOC(-4%) DRIV(-3%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.1% (StdDev 2.2%) | Hourly BBV | 0.8 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $19.86(-23.28%) | Resistance Level | $27.29 | 5 Day Moving Average | $26.02(-0.52%) | 10 Day Moving Average | $26.75(-3.23%) | 20 Day Moving Average | $27.29(-5.15%) | To recent high | -12.6% | To recent low | 0.6% | Market Cap | $3.538b | | | | Halozyme Therapeutics, Inc. is a biopharmaceutical company, which engages in research, development & commercialization of human enzymes and drug candidates. It focuses on novel oncology therapies that target the tumor microenvironment. Its products include PEGPH20, HTI-1511, PEG-ADA2, and HYLENEX recombinant. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA. |